HURA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TuHURA Biosciences Inc (HURA) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks clear positive momentum, strong financial performance, or significant catalysts to justify immediate investment. Given the investor's profile and the absence of compelling signals, it is better to hold off on this stock for now.
The stock is showing weak technical indicators. The MACD is negative and expanding downward, indicating bearish momentum. The RSI is neutral at 46.164, and moving averages are converging, suggesting indecision in price movement. The stock is trading below its pivot level of 1.865, with key support at 1.569 and resistance at 2.161.
Analyst Robert Burns from H.C. Wainwright maintains a Buy rating and sees the recent stock decline as an attractive entry point. However, this is not supported by other strong catalysts or news.
No recent news or significant trading trends from hedge funds or insiders. The financial performance shows a significant net income loss and a sharp decline in EPS (-99.71% YoY). Technical indicators are bearish, and there is no recent congress trading data to suggest interest from influential figures.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income loss of -$7,104,544 (up 252.93% YoY due to prior losses), and a significant drop in EPS (-99.71% YoY). Gross margin remains at 0%. Overall, the financials are weak with no clear growth trends.
H.C. Wainwright analyst Robert Burns lowered the price target from $12 to $10 while maintaining a Buy rating. The analyst views the stock's decline as an attractive entry point, but this is not supported by other analysts or strong financials.
